{"id":"W4286296877","doi":"10.1200/jco.2022.40.16_suppl.5078","title":"Association of prostate-specific antigen (PSA) response and overall survival (OS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the phase 3 ARASENS trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Hazard ratio; Prostate-specific antigen; Internal medicine; Oncology; Population; Androgen deprivation therapy; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003575772,0.0006256489,0.001477869,0.0002770739,0.0002287951,0.0005417485,0.000545736,0.0006599259,0.002105957],"category_scores_gemma":[0.002009696,0.0002379069,0.001753597,0.0003950674,0.0003897915,0.0004513192,0.0004908424,0.001276714,0.0002331456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003734631,"about_ca_system_score_gemma":0.0006719588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006987702,"about_ca_topic_score_gemma":0.002224632,"domain_scores_codex":[0.9991235,0.0005858067,0.00004652074,0.00009723331,0.00007693101,0.00006992815],"domain_scores_gemma":[0.9987483,0.0004246475,0.000347793,0.0001272293,0.0000658667,0.000286191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8760095,0.002219185,0.07271992,0.0008818192,0.005346166,0.0001108027,0.00009226191,0.002018968,0.002661965,0.0001200588,0.003088108,0.03473116],"study_design_scores_gemma":[0.3453718,0.1973221,0.4365804,0.0002423858,0.009230537,0.0006261652,0.0001212538,0.003748885,0.001285002,0.0008204071,0.004561157,0.00008996323],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993093,0.00379036,0.0001283461,0.000233513,0.00005290841,0.0002354131,0.001505828,0.00002184794,0.0009386999],"genre_scores_gemma":[0.9954996,0.0007961261,0.0002688389,0.0002301285,0.00008286285,0.0002516399,0.002369187,0.00000738981,0.0004944403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003575772,"threshold_uncertainty_score":0.01891071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1044979644481129,"score_gpt":0.4477058098119922,"score_spread":0.3432078453638793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}